Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
CYRX Stock Chart & Stats
$8.53
$0.06(0.70%)
At close: 4:00 PM EST
$8.53
$0.06(0.70%)
Day’s Range― - ―
52-Week Range$4.58 - $11.44
Previous CloseN/A
Volume42.91K
Average Volume (3M)690.07K
Market Cap
$461.62M
Enterprise Value$215.74M
Total Cash (Recent Filing)$425.98M
Total Debt (Recent Filing)$228.52M
Price to Earnings (P/E)―
Beta1.23
Next Earnings
Mar 11, 2026EPS Estimate
-0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding50,066,967
10 Day Avg. Volume860,552
30 Day Avg. Volume690,069
Financial Highlights & Ratios
PEG Ratio-0.26
Price to Book (P/B)0.96
Price to Sales (P/S)1.68
P/FCF Ratio-11.43
Enterprise Value/Market Cap0.47
Enterprise Value/Revenue1.06
Enterprise Value/Gross Profit2.33
Enterprise Value/Ebitda-38.80
Forecast
1Y Price Target
$13.63Price Target Upside59.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial HealthRecent sale of CryoPDP to DHL effectively removes a major cash runway overhang on shares, with the company now well capitalized with $426M of cash.
Market PositionCYRX is well positioned to beat this year as well as deliver next year on continued C> services strength, where CYRX holds a dominant market-leading position with 70% market share.
Revenue PerformanceRevenue of $44.2M was well ahead of consensus estimates, driven by both Life Sciences Services and Life Sciences Products, signaling strong demand recovery.
Bears Say
CryoPort News
CYRX FAQ
What was CryoPort Inc’s price range in the past 12 months?
CryoPort Inc lowest stock price was $4.58 and its highest was $11.44 in the past 12 months.
What is CryoPort Inc’s market cap?
CryoPort Inc’s market cap is $461.62M.
When is CryoPort Inc’s upcoming earnings report date?
CryoPort Inc’s upcoming earnings report date is Mar 11, 2026 which is in 125 days.
How were CryoPort Inc’s earnings last quarter?
CryoPort Inc released its earnings results on Nov 04, 2025. The company reported -$0.18 earnings per share for the quarter, beating the consensus estimate of -$0.223 by $0.043.
Is CryoPort Inc overvalued?
According to Wall Street analysts CryoPort Inc’s price is currently Undervalued.
Does CryoPort Inc pay dividends?
CryoPort Inc does not currently pay dividends.
What is CryoPort Inc’s EPS estimate?
CryoPort Inc’s EPS estimate is -0.21.
How many shares outstanding does CryoPort Inc have?
CryoPort Inc has 50,066,967 shares outstanding.
What happened to CryoPort Inc’s price movement after its last earnings report?
CryoPort Inc reported an EPS of -$0.18 in its last earnings report, beating expectations of -$0.223. Following the earnings report the stock price went down -7.484%.
Which hedge fund is a major shareholder of CryoPort Inc?
Currently, no hedge funds are holding shares in CYRX
CryoPort Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.63 (59.79% Upside)
$13.63 (59.79% Upside)
Hedge Fund Trend
Decreased
By 35.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $123.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 2.7%
Last 30 Days ▲ 2.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
41.93%
12-Months-Change
Fundamentals
Return on Equity
-9.96%
Trailing 12-Months
Asset Growth
-9.20%
Trailing 12-Months
Company Description
CryoPort Inc
CryoPort, Inc. (CYRX) is a logistics company specializing in temperature-controlled supply chain solutions for the life sciences sector. The company primarily serves the biopharmaceutical, cell and gene therapy, and regenerative medicine industries by providing innovative shipping solutions that ensure the integrity and viability of sensitive biological materials. CryoPort's core products include cryogenic shipping solutions, data monitoring systems, and a range of temperature-controlled packaging options designed to meet the rigorous demands of transporting critical biological samples.
CYRX Company Deck
CYRX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a mostly positive outlook with strong growth in key segments, strategic expansions, and increased clinical trial support. However, there are some concerns about sequential revenue guidance and external factors like the government shutdown impacting operations.View all CYRX earnings summariesCYRX Stock 12 Month Forecast
Average Price Target
$13.63
▲(59.79% Upside)
Technical Analysis
Ownership Overview
3.40% Insiders
18.12% Mutual Funds
3.22% Other Institutional Investors
57.93% Public Companies and
Individual Investors